Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.22 -0.08 (-6.54%)
As of: Oct 2, 2026 · 3:17 PM EDT

Alx Oncology Holdings (ALXO) Interest Expenses (2022 - 2026)

Updated

Alx Oncology Holdings (ALXO) recorded Interest Expenses of $285,000 in Q2 2026, down 29.6% from $405,000 a year earlier and down 13.9% from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Interest Expenses (2022 - 2026) Analysis & Trends

On a TTM basis, Alx Oncology Holdings' Interest Expenses came in at $1.41 million as of Jun 30, 2026, down 16.4% year-over-year; for FY2025, it came in at $1.6 million, down 7.3% from FY2024.

  • Annual Interest Expenses has a four-year compound annual growth rate of 233.2% (FY2021 to FY2025).
  • Across earlier years, Interest Expenses came in at $1.73 million in FY2024 (+10.5%), $1.57 million in FY2023 (+557.6%), $238,000 in FY2022 and $13,000 in FY2021.
  • The Q2 2026 figure is the lowest quarterly Interest Expenses since Q4 2022.
  • On a year-over-year basis, Interest Expenses has declined for six consecutive quarters, with an average decline of 7.6% over the last eight quarters.
  • Peak year-over-year performance for Interest Expenses in the last five years was growth of 79.7% in Q4 2023, against a decline of 29.6% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $331,000 (Q1 2026), $383,000 (Q4 2025) and $408,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Alx Oncology Holdings 192.12 Mn 192.12 Mn - 285,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 285,000.00
Mar 31, 2026 331,000.00
Dec 31, 2025 383,000.00
Sep 30, 2025 408,000.00
Jun 30, 2025 405,000.00
Mar 31, 2025 406,000.00
Dec 31, 2024 427,000.00
Sep 30, 2024 446,000.00
Jun 30, 2024 429,000.00
Mar 31, 2024 427,000.00
Dec 31, 2023 415,000.00
Sep 30, 2023 391,000.00
Jun 30, 2023 372,000.00
Mar 31, 2023 387,000.00
Dec 31, 2022 231,000.00
Sep 30, 2022 2,000.00
Jun 30, 2022 2,000.00
Mar 31, 2022 3,000.00
API Access

Alx Oncology Holdings Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=ALXO&period=max&api_key=YOUR_API_KEY